Manufacturers of impotence pills are facing a new challenge in the form of a nasal spray that acts in just eight minutes. The Aspirair device is similar to an asthma inhaler, and administers ...
Commercial launch of neffy® (epinephrine nasal spray) underway in the United StatesSupplemental NDA for neffy®1mg dose granted priority review by FDA; PDUFA target date set for March 6, 2025Exclusive ...